即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS号 | 1009119-64-5 | 货号 | BCP02431 |
中文名 | 达卡他韦 | ||
英文名 | Daclatasvir | ||
中文别名 | 达卡拉韦; 达拉他韦; | ||
英文别名 | BMS790052; EBP-883; EBP 883; EBP883;BMS 790052;BMS790052; Daklinza; | ||
SMILES | |||
化学名称 | |||
分子式 | C40H50N8O6 | 分子量 | 738.89 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | Daclatasvir is an orally available antiviral agent that inhibits the NS5A region of the hepatitis C virus (HCV) and is used in combination with other oral antiviral agents to treat chronic hepatitis C. Elevations in serum enzyme levels during daclatasvir therapy are uncommon, and it has yet to be convincingly implicated in cases of clinically apparent liver injury with jaundice. Nevertheless, and for unknown reasons, successful all-oral regimens of antiviral therapy in patients with chronic hepatitis C and cirrhosis is occasionally complicated by hepatic decompensation and may cause reactivation of hepatitis B in susceptible patients coinfected with the hepatitis B virus (HBV). |
相关产品推荐
查看更多 >Tags:Daclatasvir 供应商,Daclatasvir 购买,Daclatasvir 生产,Daclatasvir 批量,Daclatasvir 供应,Daclatasvir 订购,Daclatasvir 采购